| 产品描述: | InformationRO8994 is a potent and selective spiroindolinone small-molecule MDM2 inhibitor with IC50 of 5 nM and 20 nM in HTRF binding assays and MTT proliferation assays, respectively. |
| 体内研究: |
RO8994 抑制人 SJSA1 肿瘤异种移植物模型中的肿瘤生长。 |
| 参考文献: |
1. Zhang Z, et al. Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy. Bioorg Med Chem. 2014 Aug 1;22(15):4001-4009. 2. Zhang Z, et al. Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development. ACS Med Chem Lett. 2013 Dec 29;5(2):124-7. 3. Yu B, Liu H M. The development of new spirooxindoles targeting the p53–MDM2 protein-protein interactions for cancer therapy[J]. Targeting Protein-Protein Interactions by Small Molecules, 2018: 213-237. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.63 ml |
8.15 ml |
16.3 ml |
| 5 mM |
0.326 ml |
1.63 ml |
3.26 ml |
| 10 mM |
0.163 ml |
0.815 ml |
1.63 ml |
| 50 mM |
0.033 ml |
0.163 ml |
0.326 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |